Operating RegenMed

Development of better in-theater strategies for handling tissue-engineered organs and tissues

Jonathan M. Fishman, Justin C R Wormald, Mark W. Lowdell, Paolo De Coppi, Martin A. Birchall

Research output: Contribution to journalArticle

Abstract

Tissue engineering ex vivo and direct cellular application with bioscaffolds in vivo has allowed surgeons to restore and establish function throughout the human body. The evidence for regenerative surgery is growing, and consequently there is a need for the development of more advanced regenerative surgery facilities. Regenerative medicine in the surgical field is changing rapidly and this must be reflected in the design of any future operating suite. The theater environment needs to be highly adaptable to account for future significant advances within the field. Development of purpose built, combined operating suites and tissue-engineering laboratories will provide the facility for modern surgeons to treat patients with organ deficits, using bespoke, regenerated constructs without the need for immunosuppression.

Original languageEnglish (US)
Pages (from-to)785-791
Number of pages7
JournalRegenerative Medicine
Volume9
Issue number6
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Theaters
Tissue Engineering
Tissue engineering
Surgery
Tissue
Regenerative Medicine
Human Body
Immunosuppression
Surgeons

Keywords

  • biotechnology
  • operating room
  • operating theater
  • reconstruction
  • regeneration
  • regenerative medicine
  • scaffold
  • stem cells
  • surgery
  • tissue engineering

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

Operating RegenMed : Development of better in-theater strategies for handling tissue-engineered organs and tissues. / Fishman, Jonathan M.; Wormald, Justin C R; Lowdell, Mark W.; De Coppi, Paolo; Birchall, Martin A.

In: Regenerative Medicine, Vol. 9, No. 6, 01.11.2014, p. 785-791.

Research output: Contribution to journalArticle

Fishman, Jonathan M. ; Wormald, Justin C R ; Lowdell, Mark W. ; De Coppi, Paolo ; Birchall, Martin A. / Operating RegenMed : Development of better in-theater strategies for handling tissue-engineered organs and tissues. In: Regenerative Medicine. 2014 ; Vol. 9, No. 6. pp. 785-791.
@article{27f9c7cf173245619520ad58008b54a2,
title = "Operating RegenMed: Development of better in-theater strategies for handling tissue-engineered organs and tissues",
abstract = "Tissue engineering ex vivo and direct cellular application with bioscaffolds in vivo has allowed surgeons to restore and establish function throughout the human body. The evidence for regenerative surgery is growing, and consequently there is a need for the development of more advanced regenerative surgery facilities. Regenerative medicine in the surgical field is changing rapidly and this must be reflected in the design of any future operating suite. The theater environment needs to be highly adaptable to account for future significant advances within the field. Development of purpose built, combined operating suites and tissue-engineering laboratories will provide the facility for modern surgeons to treat patients with organ deficits, using bespoke, regenerated constructs without the need for immunosuppression.",
keywords = "biotechnology, operating room, operating theater, reconstruction, regeneration, regenerative medicine, scaffold, stem cells, surgery, tissue engineering",
author = "Fishman, {Jonathan M.} and Wormald, {Justin C R} and Lowdell, {Mark W.} and {De Coppi}, Paolo and Birchall, {Martin A.}",
year = "2014",
month = "11",
day = "1",
doi = "10.2217/rme.14.46",
language = "English (US)",
volume = "9",
pages = "785--791",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Operating RegenMed

T2 - Development of better in-theater strategies for handling tissue-engineered organs and tissues

AU - Fishman, Jonathan M.

AU - Wormald, Justin C R

AU - Lowdell, Mark W.

AU - De Coppi, Paolo

AU - Birchall, Martin A.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Tissue engineering ex vivo and direct cellular application with bioscaffolds in vivo has allowed surgeons to restore and establish function throughout the human body. The evidence for regenerative surgery is growing, and consequently there is a need for the development of more advanced regenerative surgery facilities. Regenerative medicine in the surgical field is changing rapidly and this must be reflected in the design of any future operating suite. The theater environment needs to be highly adaptable to account for future significant advances within the field. Development of purpose built, combined operating suites and tissue-engineering laboratories will provide the facility for modern surgeons to treat patients with organ deficits, using bespoke, regenerated constructs without the need for immunosuppression.

AB - Tissue engineering ex vivo and direct cellular application with bioscaffolds in vivo has allowed surgeons to restore and establish function throughout the human body. The evidence for regenerative surgery is growing, and consequently there is a need for the development of more advanced regenerative surgery facilities. Regenerative medicine in the surgical field is changing rapidly and this must be reflected in the design of any future operating suite. The theater environment needs to be highly adaptable to account for future significant advances within the field. Development of purpose built, combined operating suites and tissue-engineering laboratories will provide the facility for modern surgeons to treat patients with organ deficits, using bespoke, regenerated constructs without the need for immunosuppression.

KW - biotechnology

KW - operating room

KW - operating theater

KW - reconstruction

KW - regeneration

KW - regenerative medicine

KW - scaffold

KW - stem cells

KW - surgery

KW - tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84913610543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913610543&partnerID=8YFLogxK

U2 - 10.2217/rme.14.46

DO - 10.2217/rme.14.46

M3 - Article

VL - 9

SP - 785

EP - 791

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 6

ER -